# Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

> **NCT00582205** · PHASE2 · TERMINATED · sponsor: **University of Oklahoma** · enrollment: 21 (actual)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma
- Uterine Cancer

## Interventions

- **DRUG:** Paclitaxel, Cisplatin IP

## Key facts

- **NCT ID:** NCT00582205
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Study completed per investigator.
- **Last updated:** 2021-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00582205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00582205, "Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00582205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*